Hydroxyprogesterone caproate for preterm birth: A situational analysis from the Indian perspective
Background: Preterm birth can cause morbidity and mortality in addition to trauma or loss to the mother, and present a major financial burden to the family. This risk may be minimized by timely intervention. Objective: To understand the safety and efficacy of hydroxyprogesterone in decreasing the in...
Saved in:
Main Authors: | Pugazhenthan Thangaraju (Author), Shoban Babu Varthya (Author), Prakash Srinivasan Timiri Shanmugam (Author), T.Y. Sree Sudha (Author), Chaitanya Mittal (Author) |
---|---|
Format: | Book |
Published: |
BMJ Publishing Group,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021) -
Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
by: Kim A. Boggess, et al.
Published: (2018) -
Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California
by: Subhashini Ladella, et al.
Published: (2021) -
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
by: Carla E. Ransom, et al.
Published: (2011) -
Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020)